Drug Pipeline

QT-019C Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 1
1
Early Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07315087 CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory… SLE - Systemic Lupus Erythematosus Recruiting
Early Phase 1
NCT07392528 Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/… Neuromyelitis Optica Spectrum Disorders Not Yet Recruiting
NCT07416032 A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic… Immune Thrombocytopenia (ITP) Not Yet Recruiting
Sponsors Running QT-019C Trials
Institute of Hematology & Blood Diseases Hospital, China (1) Tianjin Huanhu Hospital (1) Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)
Disease Areas
Lupus (SLE) (1) Scleroderma (1) Multiple Sclerosis (1) Myasthenia Gravis (1)
Get alerts when QT-019C trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free